Hypertrophic pachymeningitis (Q97636): Difference between revisions
From determinar.ia.br - Determine suas informações
Changed label, description and/or aliases in pt-br, en |
Changed an Item |
||
| Property / Canonical URI | |||
| Property / Canonical URI: https://id.who.int/icd/entity/1561437485 / rank | |||
Normal rank | |||
Revision as of 13:45, 16 August 2026
Hypertrophic pachymeningitis is characterised by localised or diffuse thickening of the dura mater. It may be idiopathic or secondary to inflammatory disorders, infections, immune-mediated disorders and malignancies. The cranial dura, spinal dura or both may be involved. The clinical features reflect the part of the neuraxis affected and may include headache, cranial nerve palsies, ataxia, paraparesis, sensory loss and loss of sphincter control. Diagnosis may be confirmed by neuroimaging, spinal fluid analysis and meningeal biopsy.
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | ID_1561437485 |
||
| English | Hypertrophic pachymeningitis |
Hypertrophic pachymeningitis is characterised by localised or diffuse thickening of the dura mater. It may be idiopathic or secondary to inflammatory disorders, infections, immune-mediated disorders and malignancies. The cranial dura, spinal dura or both may be involved. The clinical features reflect the part of the neuraxis affected and may include headache, cranial nerve palsies, ataxia, paraparesis, sensory loss and loss of sphincter control. Diagnosis may be confirmed by neuroimaging, spinal fluid analysis and meningeal biopsy. |
